Quickly release the clinical data.
Quickly release the clinical data.
GlycoMimetics highlighted two posters at the 2021 ASH conference; the posters highlighted the potential of the dual antagonist GMI-1359 targeting CXCR4 and E-Selectin.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
